Literature DB >> 7509921

Functional domains of human endothelin receptor.

M Adachi1, K Hashido, A Trzeciak, T Watanabe, Y Furuichi, C Miyamoto.   

Abstract

The ligand binding site to the ETA receptor was investigated by substitution of each 5-amino acid sequence located in the second extracellular (B) region of the ETA receptor with the cognate sequences of the beta 2-adrenergic receptor. A 5-amino acid sequence (140-KLLAG-144) in the B-loop region was implicated as the most important element required for ligand binding. In addition, both the third and the fourth extracellular regions (C- and D-loops), including the flanking transmembrane regions, were found to play an important role in ligand selection. As for the biological significance of the intracellular regions of the ETA receptor, we have found that the C-terminal 8-amino acid residues located in close proximity to the seventh transmembrane region and the C-terminal 16-amino acid residues in the third intracellular loop are important for the binding of ET-1. Therefore, the intracellular third loop and C-terminal domains seem to contribute to the three-dimensional structure of the ligand binding site located in the extracellular domains. The same lines of experiment showed that the ETA receptor requires > 13 amino acid residues at the proximal cytoplasmic tail and 10 amino acid residues in the C-terminal region of the third intracellular loop to induce an ET-1-dependent increase in [Ca2+]i. Both regions are possibly involved in the interaction with G-protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7509921     DOI: 10.1097/00005344-199322008-00033

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  3 in total

Review 1.  Structural basis of the function of endothelin receptor.

Authors:  T Masaki; H Ninomiya; A Sakamoto; Y Okamoto
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Investigating the specificity of endothelin-traps as a potential therapeutic tool for endothelin-1 related disorders.

Authors:  Arjun Jain; Kristof Bozovicar; Vidhi Mehrotra; Tomaz Bratkovic; Martin H Johnson; Ira Jha
Journal:  World J Diabetes       Date:  2022-06-15

3.  Expression of endothelin system in neuroblastic tumors: close association of endothelin-1 and endothelin B receptor expression with differentiation of tumor cells.

Authors:  Nobuo Hoshi; Takashi Sugino; Toshimitsu Suzuki
Journal:  Med Mol Morphol       Date:  2009-06-18       Impact factor: 2.309

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.